The impact of hydroxyethyl starches in cardiac surgery: A meta-analysis

Critical Care

Volumn 18, Issue 6, 2014, Pages

  Jacob, Matthias ^a   Fellahi, Jean Luc ^b,c   Chappell, Daniel ^d   Kurz, Andrea ^e  

^a Munich Municipal Hospital   (Germany)

^b LOUIS PRADEL HOSPITAL   (France)

^c UNIVERSITÉ LYON 1   (France)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e Department of General Anesthesiology Cleveland Clinic Main Campus ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GELATIN; HETASTARCH; CRYSTALLOID; HETASTARCH DERIVATIVE; ISOTONIC SOLUTION; PLASMA SUBSTITUTE;

ACUTE KIDNEY FAILURE; ARTICLE; BLEEDING; BLOOD TRANSFUSION; COCHRANE LIBRARY; COLLOID; CRYSTALLOID; EMBASE; HEART SURGERY; HUMAN; INFORMATION RETRIEVAL; INTENSIVE CARE UNIT; LENGTH OF STAY; MEDLINE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REOPERATION; RISK BENEFIT ANALYSIS; SAFETY; SYSTEMATIC REVIEW; ADVERSE EFFECTS; BLOOD LOSS, SURGICAL; PROCEDURES; UTILIZATION;

BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; ISOTONIC SOLUTIONS; PLASMA SUBSTITUTES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84925649553     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-014-0656-0     Document Type: Article

References (74)

1. Westphal M, James MF, Kozek-Langenecker SA, Stocker R, Guidet B, Van Aken H. Hydroxyethyl starches: different products-different effects. Anesthesiology 2009, 111:187-202. 10.1097/ALN.0b013e3181a7ec82, 19512862.
2. Van Der Linden PJ, James M, Mythen M, Weiskopf RB. Safety of modern starches used during surgery. Anesth Analg 2013, 116:35-48. 10.1213/ANE.0b013e31827175da.
3. Martin C, Jacob M, Vicaut E, Guidet B, Van Aken H, Kurz A. Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology 2013, 118:387-394. 10.1097/ALN.0b013e31827e5569, 23340352.
4. Gillies MA, Habicher M, Jhanji S, Sander M, Mythen M, Hamilton M, Pearse RM. Incidence of postoperative death and acute kidney injury associated with i.v. 6% hydroxyethyl starch use: systematic review and meta-analysis. Br J Anaesth 2014, 112:25-34. 10.1093/bja/aet303, 24046292.
5. Shi X, Zou Z, He X, Xu H, Yuan H, Liu H. Hydroxyethyl starch for cardiovascular surgery: a systematic review of randomized controlled trials. Eur J Clin Pharmacol 2011, 67:767-782. 10.1007/s00228-011-1008-5, 21365330.
6. Shafer SL. Shadow of doubt. Anesth Analg 2011, 112:498-500. 10.1213/ANE.0b013e31820ad3b7, 21296856.
7. Ali MA, Saleh M. Selection of optimal quantity of hydroxyethyl starch in the cardiopulmonary bypass prime. Perfusion 2004, 19:41-45. 10.1191/0267659104pf705oa, 15072254.
8. Navickis RJ, Haynes GR, Wilkes MM. Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: a meta-analysis of randomized trials. J Thorac Cardiovasc Surg 2012, 144:223-230. 10.1016/j.jtcvs.2012.04.009, 22578894.
9. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010, 8:336-341. 10.1016/j.ijsu.2010.02.007, 20171303.
10. Deeks JJ, Altman DG, Bradburn MJ: Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd edition. Edited by Egger M, Smith GD, Altman DG. London: BMJ Publishing Group; 2001:285-312..
11. Akkucuk FG, Kanbak M, Ayhan B, Celebioglu B, Aypar U. The effect of HES (130/0.4) usage as the priming solution on renal function in children undergoing cardiac surgery. Ren Fail 2013, 35:210-215. 10.3109/0886022X.2012.747139, 23228215.
12. Boks RH, Wijers MJ, Hofland J, Takkenberg JJ, Bogers AJ. Low molecular starch versus gelatin plasma expander during CPB: Does it make a difference?. Perfusion 2007, 22:333-337. 10.1177/0267659107086656, 18416219.
13. Brock H, Rapf B, Necek S, Gabriel C, Peterlik C, Pölz W, Schimetta W, Bergmann H. Comparison of postoperative volume therapy in heart surgery patients [Article in German]. Anaesthesist 1995, 44:486-492. 10.1007/s001010050181, 7661335.
14. Brutocao D, Bratton SL, Thomas JR, Schrader PF, Coles PG, Lynn AM. Comparison of hetastarch with albumin for postoperative volume expansion in children after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1996, 10:348-351. 10.1016/S1053-0770(96)80095-4, 8725415.
15. Chakravarthy M, Muniraj G, Patil S, Suryaprakash S, Mitra S, Shivalingappa B. A randomized prospective analysis of alteration of hemostatic function in patients receiving tranexamic acid and hydroxyethyl starch (130/0.4) undergoing off pump coronary artery bypass surgery. Ann Card Anaesth 2012, 15:105-110. 10.4103/0971-9784.95072, 22508200.
16. Choi YS, Shim JK, Hong SW, Kim JC, Kwak YL. Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass. Minerv Anestesiol 2010, 76:584-591.
17. Diehl JT, Lester JL, Cosgrove DM. Clinical comparison of hetastarch and albumin in postoperative cardiac patients. Ann Thorac Surg 1982, 34:674-679. 10.1016/S0003-4975(10)60907-1, 6184023.
18. Eising GP, Niemeyer M, Günther T, Tassani P, Pfauder M, Schad H, Lange R. Does a hyperoncotic cardiopulmonary bypass prime affect extravascular lung water and cardiopulmonary function in patients undergoing coronary artery bypass surgery?. Eur J Cardiothorac Surg 2001, 20:282-289. 10.1016/S1010-7940(01)00804-1, 11463545.
19. Gurbuz HA, Durukan AB, Salman N, Tavlasoglu M, Durukan E, Ucar H, Yorgancioglu C. Hydroxyethyl starch 6%, 130/0.4 vs. a balanced crystalloid solution in cardiopulmonary bypass priming: a randomized, prospective study. J Cardiothorac Surg 2013, 8:71. 10.1186/1749-8090-8-71, 23566712.
20. Kimenai D, Bastianen G, Daane C, Megens-Bastiaanse C, van der Meer N, Scohy T, Gerritse BM. Effect of the colloids gelatin and HES 130/0.4 on blood coagulation in cardiac surgery patients: a randomized controlled trial. Perfusion 2013, 28:512-519. 10.1177/0267659113491446, 23744847.
21. Kirklin JK, Lell WA, Kouchoukos NT. Hydroxyethyl starch versus albumin for colloid infusion following cardiopulmonary bypass in patients undergoing myocardial revascularization. Ann Thorac Surg 1984, 37:40-46. 10.1016/S0003-4975(10)60707-2, 6197944.
22. Kuitunen A, Suojaranta-Ylinen R, Kukkonen S, Niemi T. A comparison of the haemodynamic effects of 4% succinylated gelatin, 6% hydroxyethyl starch (200/0.5) and 4% human albumin after cardiac surgery. Scand J Surg 2007, 96:72-78. 17461317.
23. Ley SJ, Miller K, Skov P, Preisig P. Crystalloid versus colloid fluid therapy after cardiac surgery. Heart Lung 1990, 19:31-40. 1688835.
24. London MJ, Franks M, Verrier ED, Merrick SH, Levin J, Mangano DT. The safety and efficacy of ten percent pentastarch as a cardiopulmonary bypass priming solution: a randomized clinical trial. J Thorac Cardiovasc Surg 1992, 104:284-296. 1379660.
25. London MJ, Ho JS, Triedman JK, Verrier ED, Levin J, Merrick SH, Hanley FL, Browner WS, Mangano DT. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. J Thorac Cardiovasc Surg 1989, 97:785-797. 2468978.
26. Mastroianni L, Low HB, Rollman J, Wagle M, Bleske B, Chow MS. A comparison of 10% pentastarch and 5% albumin in patients undergoing open-heart surgery. J Clin Pharmacol 1994, 34:34-40. 10.1002/j.1552-4604.1994.tb03963.x, 7510728.
27. Mehta Y, Dhar A, Sujatha, Meharwal Z, Trehan N: Comparison of new HES (130/0.4) and HES (200/0.5) in OPCAB surgery. J Anaesthesiol Clin Pharmacol 2007, 23:273-278..
28. Moggio RA, Rha CC, Somberg ED, Praeger PI, Pooley RW, Reed GE. Hemodynamic comparison of albumin and hydroxyethyl starch in postoperative cardiac surgery patients. Crit Care Med 1983, 11:943-945. 10.1097/00003246-198312000-00009, 6196155.
29. Molter GP, Soltész S, Larsen R, Baumann-Noss S, Biedler A, Silomon M. Haemodynamic effects following preoperative hypervolemic haemodilution with hypertonic hyperoncotic colloid solutions in coronary artery bypass graft surgery [Article in German]. Anaesthesist 2003, 52:905-918. 10.1007/s00101-003-0568-x, 14618246.
30. Muralidhar K, Garg R, Mohanty S, Banakal S. Influence of colloid infusion on coagulation during off-pump coronary artery bypass grafting. Indian J Anaesth 2010, 54:147-153. 10.4103/0019-5049.63653, 20661354.
31. Niemi TT, Suojaranta-Ylinen RT, Kukkonen SI, Kuitunen AH. Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesth Analg 2006, 102:998-1006. 10.1213/01.ane.0000200285.20510.b6, 16551888.
32. Niemi T, Schramko A, Kuitunen A, Kukkonen S, Suojaranta-Ylinen R. Haemodynamics and acid-base equilibrium after cardiac surgery: comparison of rapidly degradable hydroxyethyl starch solutions and albumin. Scand J Surg 2008, 97:259-265. 18812277.
33. Saunders CR, Carlisle L, Bick RL. Hydroxyethyl starch versus albumin in cardiopulmonary bypass prime solutions. Ann Thorac Surg 1983, 36:532-539. 10.1016/S0003-4975(10)60683-2, 6195981.
34. Saxena N. A Comparison of hetastarch, albumin and Ringer lactate for volume replacement in coronary artery bypass surgery. J Anaesth Clin Pharmacol 1997, 13:117-120.
35. Schramko AA, Suojaranta-Ylinen RT, Kuitunen AH, Kukkonen SI, Niemi TT. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Anesth Analg 2009, 108:30-36. 10.1213/ane.0b013e31818c1282, 19095827.
36. Shahbazi S, Zeighami D, Allahyary E, Alipour A, Esmaeeli M, Ghaneie M. Effect of colloid versus crystalloid administration of cardiopulmonary bypass prime solution on tissue and organ perfusion. Int Cardiovasc Res J 2011, 5:24-31.
37. Tigchelaar I, Gallandat HRC, Boonstra PW, van Oeveren W. Comparison of three plasma expanders used as priming fluids in cardiopulmonary bypass patients. Perfusion 1998, 13:297-303. 10.1177/026765919801300503, 9778712.
38. Van der Linden PJ, de Hert SG, Daper A, Trenchant A, Schmartz D, Defrance P, Kimbimbi P. 3.5% urea-linked gelatin is as effective as 6% HES 200/0.5 for volume management in cardiac surgery patients. Can J Anaesth 2004, 51:236-241. 10.1007/BF03019102, 15010405.
39. Yen TS, Chan KC, Cheng YJ. Intraoperative coagulation was more interfered by HES 200/0.5 than normal saline in off-pump coronary artery bypass surgery. J Cardiovasc Surg 2008, 49:679-684.
40. Kuitunen AH, Hynynen MJ, Vahtera E, Salmenperä MT. Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery. Anesth Analg 2004, 98:291-297. 10.1213/01.ANE.0000096006.60716.F6, 14742357.
41. Palanzo DA, Parr GV, Bull AP, Williams DR, O'Neill MJ, Waldhausen JA. Hetastarch as a prime for cardiopulmonary bypass. Ann Thorac Surg 1982, 34:680-683. 10.1016/S0003-4975(10)60908-3, 6184024.
42. Tiryakioğlu O, Yi{dotless}ldi{dotless}z G, Vural H, Goncu T, Ozyazi{dotless}ci{dotless}oglu A, Yavuz T. Hydroxyethyl starch versus Ringer solution in cardiopulmonary bypass prime solutions (a randomized controlled trial). J Cardiothorac Surg 2008, 3:45. 10.1186/1749-8090-3-45, 18620591.
43. Hanart C, Khalife M, de Villé A, Otte F, de Hert S, Van der Linden PJ. Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4. Crit Care Med 2009, 37:696-701. 10.1097/CCM.0b013e3181958c81, 19114887.
44. Hecht-Dolnik M, Barkan H, Taharka A, Loftus J. Hetastarch increases the risk of bleeding complications in patients after off-pump coronary bypass surgery: a randomized clinical trial. J Thorac Cardiovasc Surg 2009, 138:703-711. 10.1016/j.jtcvs.2009.02.035, 19698859.
45. Iriz E, Kolbakir F, Akar H, Adam B, Keceligil HT. Comparison of hydroxyethyl starch and ringer lactate as a prime solution regarding S-100β protein levels and informative cognitive tests in cerebral injury. Ann Thorac Surg 2005, 79:666-671. 10.1016/j.athoracsur.2004.08.002, 15680855.
46. Kasper SM, Meinert P, Kampe S, Görg C, Geisen C, Mehlhorn U, Diefenbach C. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses. Anesthesiology 2003, 99:42-47. 10.1097/00000542-200307000-00010, 12826840.
47. Lee JS, Ahn SW, Song JW, Shim JK, Yoo KJ, Kwak YL. Effect of hydroxyethyl starch 130/0.4 on blood loss and coagulation in patients with recent exposure to dual antiplatelet therapy undergoing off-pump coronary artery bypass graft surgery. Circ J 2011, 75:2397-2402. 10.1253/circj.CJ-11-0404, 21817820.
48. Lou S, Bian L, Long C, Wang Z, Ma J, Zhou B. Does 6% hydroxyethyl starch 130/0.4 impact differently on blood glucose than 4% gelatin in patients receiving open heart surgery?. Perfusion 2012, 27:113-118. 10.1177/0267659111426920, 22002968.
49. Mulavisala KP, Kulkarni V, Mudunuri R, Viswanath VR, Byalal JR, Gopal PB, Kulkarni SS. Hydroxyethyl starch 130/0.4 versus modified succinylated gelatin for volume expansion in pediatric cardiac surgery patients: the effects on perioperative bleeding and transfusion needs. Transfus Altern Transfus Med 2012, 12:51-58. 10.1111/j.1778-428X.2012.01169.x.
50. Ooi JS, Ramzisham AR, Zamrin MD. Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery?. Asian Cardiovasc Thorac Ann 2009, 17:368-372. 10.1177/0218492309338101, 19713332.
51. Schramko A, Suojaranta-Ylinen R, Kuitunen A, Raivio P, Kukkonen S, Niemi T. Hydroxyethylstarch and gelatin solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Br J Anaesth 2010, 104:691-697. 10.1093/bja/aeq084, 20388624.
52. Van der Linden PJ, de Hert SG, Deraedt D, Cromheecke S, de Decker K, de Paep R, Rodrigus I, Daper A, Trenchant A. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs. Anesth Analg 2005, 101:629-634. 10.1213/01.ANE.0000175216.53374.27, 16115963.
53. Alavi SM, Ahmadi BB, Baharestani B, Babaei T. Comparison of the effects of gelatin, Ringer's solution and a modern hydroxylethyl starch solution after coronary artery bypass graft surgery. Cardiovasc J Afr 2012, 23:428-431. 10.5830/CVJA-2012-026, 23044498.
54. Ertmer C, Wulf H, van Aken H, Friederich P, Mahl C, Bepperling F, Westphal M, Gogarten W. Efficacy and safety of 10% HES 130/0.4 versus 10% HES 200/0.5 for plasma volume expansion in cardiac surgery patients. Minerva Med 2012, 103:111-122. 22513516.
55. Gallandat HRC, Siemons AW, Baus D, van Rooyen-Butijn WT, Haagenaars JA, van Oeveren W, Bepperling F. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anaesth 2000, 47:1207-1215. 10.1007/BF03019870.
56. Järvelä K, Koskinen M, Kaukinen S, Kööbi T. Effects of hypertonic saline (7.5%) on extracellular fluid volumes compared with normal saline (0.9%) and 6% hydroxyethyl starch after aortocoronary bypass graft surgery. J Cardiothorac Vasc Anest 2001, 15:210-215. 10.1053/jcan.2001.21964.
57. Kuitunen A, Hynynen M, Salmenperä M, Heinonen J, Vahtera E, Verkkala K, Myllylä G. Hydroxyethyl starch as a prime for cardiopulmonary bypass: effects of two different solutions on haemostasis. Acta Anaesthesiol Scand 1993, 37:652-658. 10.1111/j.1399-6576.1993.tb03783.x, 7504387.
58. Liou HL, Shih CC, Chao YF, Lin NT, Lai ST, Wang SH, Chen HI. Inflammatory response to colloids compared to crystalloid priming in cardiac surgery patients with cardiopulmonary bypass. Chin J Physiol 2012, 55:210-218. 10.4077/CJP.2012.BAA028, 22784287.
59. Magder S, Potter BJ, Varennes BD, Doucette S, Fergusson D. Fluids after cardiac surgery: a pilot study of the use of colloids versus crystalloids. Crit Care Med 2010, 38:2117-2124. 10.1097/CCM.0b013e3181f3e08c, 20802322.
60. Vanhoonacker J, Ongenae M, Vanoverschelde H, Donadoni R. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for cardiopulmonary bypass priming: the effects on postoperative bleeding and volume expansion needs after elective CABG. Acta Anaesthesiol Belg 2009, 60:91-97. 19594090.
61. Yap WW, Young D, Pathi V. Effects of gelatine and medium molecular weight starch as priming fluid in cardiopulmonary bypass-a randomised controlled trial. Perfusion 2007, 22:57-61. 10.1177/0267659107077903, 17633136.
62. Treib J, Haass A, Pindur G, Seyfert UT, Treib W, Grauer MT, Wenzel E, Schimrigk K. HES 200/0.5 is not HES 200/0.5: influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics. Thromb Haemost 1995, 74:1452-1456. 8772219.
63. Treib J, Haass A, Pindur G, Treib W, Wenzel E, Schimrigk K. Influence of intravascular molecular weight of hydroxyethyl starch on platelets. Eur J Haematol 1996, 56:168-172. 10.1111/j.1600-0609.1996.tb01337.x, 8598237.
64. Kozek-Langenecker SA, Jungheinrich C, Sauermann W, Van der Linden PJ. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials. Anesth Analg 2008, 107:382-390. 10.1213/ane.0b013e31817e6eac, 18633012.
65. Van der Linden PJ, de Villé A, Hofer A, Heschl M, Gombotz H. Six percent hydroxyethyl starch 130/0.4 (Voluven) versus 5% human serum albumin for volume replacement therapy during elective open-heart surgery in pediatric patients. Anesthesiology 2013, 119:1296-1309. 10.1097/ALN.0b013e3182a6b387, 23934169.
66. Chappell D, Jacob M, Hofmann-Kiefer K, Conzen P, Rehm M. A rational approach to perioperative fluid management. Anesthesiology 2008, 109:723-740. 10.1097/ALN.0b013e3181863117, 18813052.
67. Hartog CS, Bauer M, Reinhart K. The efficacy and safety of colloid resuscitation in the critically ill. Anesth Analg 2011, 112:156-164. 10.1213/ANE.0b013e3181eaff91, 21127276.
68. Lobo DN, Stanga Z, Aloysius MM, Wicks C, Nunes QM, Ingram KL, Risch L, Allison SP. Effect of volume loading with 1 liter intravenous infusions of 0.9% saline, 4% succinylated gelatine (Gelofusine) and 6% hydroxyethyl starch (Voluven) on blood volume and endocrine responses: a randomized, three-way crossover study in healthy volunteers. Crit Care Med 2010, 38:464-470. 10.1097/CCM.0b013e3181bc80f1, 19789444.
69. Jacob M, Rehm M, Orth V, Lötsch M, Brechtelsbauer H, Weninger E, Finsterer U. Exact measurement of the volume effect of 6% hydoxyethyl starch 130/0.4 (Voluven) during acute preoperative normovolemic hemodilution [Article in German]. Anaesthesist 2003, 52:896-904. 10.1007/s00101-003-0557-0, 14618245.
70. Riddez L, Hahn RG, Brismar B, Strandberg A, Svensén C, Hedenstierna G. Central and regional hemodynamics during acute hypovolemia and volume substitution in volunteers. Crit Care Med 1997, 25:635-640. 10.1097/00003246-199704000-00013, 9142028.
71. Baron JF, De Kegel D, Prost AC, Mundler O, Arthaud M, Basset G, Maistre G, Masson F, Carayon A, Landault C, Barré E, Viars P. Low molecular weight hydroxyethyl starch 6% compared to albumin 4% during intentional hemodilution. Intensive Care Med 1991, 17:141-148. 10.1007/BF01704717, 1712801.
72. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AL, Fabritius ML, Mondrup F, Pott FC, Møller TP, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012, 367:124-134. A published erratum appears in N Engl J Med 2012, 367:481, 10.1056/NEJMoa1204242, 22738085.
73. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SA. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012, 367:1901-1911. 10.1056/NEJMoa1209759, 23075127.
74. Chappell D, Westphal M, Jacob M. The impact of the glycocalyx on microcirculatory oxygen distribution in critical illness. Curr Opin Anaesthesiol 2009, 22:155-162. 10.1097/ACO.0b013e328328d1b6, 19307890.